145 related articles for article (PubMed ID: 29278876)
1. Elevated levels of serum nidogen-2 in esophageal squamous cell carcinoma.
Chai AWY; Cheung AKL; Dai W; Ko JMY; Lee NPY; Chan KT; Law SY; Lung ML
Cancer Biomark; 2018 Feb; 21(3):583-590. PubMed ID: 29278876
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of pre-operative serum uric acid levels in esophageal squamous cell carcinoma patients who undergo R0 esophagectomy.
Chen YF; Li Q; Chen DT; Pan JH; Chen YH; Wen ZS; Zeng WA
Cancer Biomark; 2016 Jun; 17(1):89-96. PubMed ID: 27314297
[TBL] [Abstract][Full Text] [Related]
3. Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma.
Dong J; Zeng BH; Xu LH; Wang JY; Li MZ; Zeng MS; Liu WL
J Transl Med; 2010 Sep; 8():81. PubMed ID: 20813067
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of serum matrix metalloproteinase-13 levels in patients with esophageal squamous cell carcinoma (ESCC).
Jiao XL; Chen D; Wang JG; Zhang KJ
Eur Rev Med Pharmacol Sci; 2014; 18(4):509-15. PubMed ID: 24610617
[TBL] [Abstract][Full Text] [Related]
5. Chitinase 3-like 1 secreted by peritumoral macrophages in esophageal squamous cell carcinoma is a favorable prognostic factor for survival.
Xing S; Zheng X; Zeng T; Zeng MS; Zhong Q; Cao YS; Pan KL; Wei C; Hou F; Liu WL
World J Gastroenterol; 2017 Nov; 23(43):7693-7704. PubMed ID: 29209110
[TBL] [Abstract][Full Text] [Related]
6. Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma.
Cui Y; Xue Y; Dong S; Zhang P
J Int Med Res; 2017 Aug; 45(4):1310-1317. PubMed ID: 28587538
[TBL] [Abstract][Full Text] [Related]
7. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.
Guan S; Wang C; Chen X; Liu B; Tan B; Liu F; Wang D; Han L; Wang L; Huang X; Wang J; Yao B; Shi J; Chen P; Nesa EU; Song Q; Cheng Y
Tumour Biol; 2016 Apr; 37(4):4383-91. PubMed ID: 26499784
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels of autoantibodies against L1-cell adhesion molecule as a potential diagnostic biomarker in esophageal squamous cell carcinoma.
Xu YW; Peng YH; Ran LQ; Zhai TT; Guo HP; Qiu SQ; Chen HL; Wu ZY; Li EM; Xie JJ
Clin Transl Oncol; 2017 Jul; 19(7):898-906. PubMed ID: 28181176
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.
Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Meng YQ; Fu XY; Ma QL; Lin P
World J Gastroenterol; 2015 May; 21(18):5591-7. PubMed ID: 25987784
[TBL] [Abstract][Full Text] [Related]
10. Serum HOTAIR as a novel diagnostic biomarker for esophageal squamous cell carcinoma.
Wang W; He X; Zheng Z; Ma X; Hu X; Wu D; Wang M
Mol Cancer; 2017 Apr; 16(1):75. PubMed ID: 28376832
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic value of serum L1-cell adhesion molecule in esophageal squamous cell carcinoma.
Xu YW; Hong CQ; Wu ZY; Peng YH; Ran LQ; Yang SH; Huang BS; Liang XY; Chen HL; Wu JY; Xu XE; Deng JW; Zou HY; Fang WK; Li EM; Xu LY; Xie JJ
Clin Res Hepatol Gastroenterol; 2018 Dec; 42(6):597-603. PubMed ID: 30219694
[TBL] [Abstract][Full Text] [Related]
12. Serum clusterin as a tumor marker and prognostic factor for patients with esophageal cancer.
Guo W; Ma X; Xue C; Luo J; Zhu X; Xiang J; Lu B; Li H
Dis Markers; 2014; 2014():168960. PubMed ID: 25574066
[TBL] [Abstract][Full Text] [Related]
13. Metastasis-suppressing NID2, an epigenetically-silenced gene, in the pathogenesis of nasopharyngeal carcinoma and esophageal squamous cell carcinoma.
Chai AW; Cheung AK; Dai W; Ko JM; Ip JC; Chan KW; Kwong DL; Ng WT; Lee AW; Ngan RK; Yau CC; Tung SY; Lee VH; Lam AK; Pillai S; Law S; Lung ML
Oncotarget; 2016 Nov; 7(48):78859-78871. PubMed ID: 27793011
[TBL] [Abstract][Full Text] [Related]
14. Combined detection of serum Dickkopf-1 and its autoantibodies to diagnose esophageal squamous cell carcinoma.
Peng YH; Xu YW; Guo H; Huang LS; Tan HZ; Hong CQ; Li SS; Xu LY; Li EM
Cancer Med; 2016 Jul; 5(7):1388-96. PubMed ID: 26988995
[TBL] [Abstract][Full Text] [Related]
15. Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
He FC; Meng WW; Qu YH; Zhou MX; He J; Lv P; Ming L
World J Gastroenterol; 2015 Apr; 21(15):4660-5. PubMed ID: 25914476
[TBL] [Abstract][Full Text] [Related]
16. The association between serum Dickkopf-1 levels and esophageal squamous cell carcinoma.
Begenik H; Kemik AS; Emre H; Dulger AC; Demirkiran D; Ebinc S; Kemik O
Hum Exp Toxicol; 2014 Aug; 33(8):785-8. PubMed ID: 24220876
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of serum high-mobility group box 1 detection in esophageal squamous cell carcinoma].
Chen CG; Cui L; Tang P; Yu ZT
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Sep; 16(9):838-41. PubMed ID: 24061989
[TBL] [Abstract][Full Text] [Related]
18. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma.
Tong YS; Wang XW; Zhou XL; Liu ZH; Yang TX; Shi WH; Xie HW; Lv J; Wu QQ; Cao XF
Mol Cancer; 2015 Jan; 14():3. PubMed ID: 25608466
[TBL] [Abstract][Full Text] [Related]
19. Plasma Riboflavin Level is Associated with Risk, Relapse, and Survival of Esophageal Squamous Cell Carcinoma.
Li SS; Xu YW; Wu JY; Tan HZ; Wu ZY; Xue YJ; Zhang JJ; Li EM; Xu LY
Nutr Cancer; 2017 Jan; 69(1):21-28. PubMed ID: 27898225
[TBL] [Abstract][Full Text] [Related]
20. Expression of klotho and β-catenin in esophageal squamous cell carcinoma, and their clinicopathological and prognostic significance.
Tang X; Fan Z; Wang Y; Ji G; Wang M; Lin J; Huang S
Dis Esophagus; 2016 Apr; 29(3):207-14. PubMed ID: 25287007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
